PetMed ExpressPETS
PETS
About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Employees: 287
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
765% more call options, than puts
Call options by funds: $1.51M | Put options by funds: $174K
5.29% less ownership
Funds ownership: 43.3% [Q4 2024] → 38.01% (-5.29%) [Q1 2025]
16% less funds holding
Funds holding: 85 [Q4 2024] → 71 (-14) [Q1 2025]
24% less capital invested
Capital invested by funds: $43.1M [Q4 2024] → $32.9M (-$10.2M) [Q1 2025]
48% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 27
62% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 21
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$3.20
10%
downside
Avg. target
$3.20
10%
downside
High target
$3.20
10%
downside
1 analyst rating
0 positive
0%
0 neutral
0%
1 negative
100%
Morgan Stanley Erin Wright | 10%downside $3.20 | Underweight Maintained | 17 Apr 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
4 days ago
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call
DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process.
Neutral
GlobeNewsWire
2 weeks ago
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025.
Neutral
GlobeNewsWire
1 month ago
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem
Neutral
GlobeNewsWire
2 months ago
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025.
Neutral
GlobeNewsWire
2 months ago
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and former Chairman Dr. Gian Fulgoni will retire DELRAY BEACH, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Peter Batushansky to the Company's Board of Directors (“the Board”), effective April 09, 2025.
Neutral
Seeking Alpha
4 months ago
PetMed Express, Inc. (PETS) Q3 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Reed Anderson - IR, ICR Sandra Campos - CEO and President Robyn D'Elia - CFO Conference Call Participants Erin Wright - Morgan Stanley Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Positive
Seeking Alpha
4 months ago
PetMed Express: Dip Or Rip, A Buy After Earnings
PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-term upside.
Positive
Zacks Investment Research
5 months ago
Here's Why PetMed (PETS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
6 months ago
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
GlobeNewsWire
6 months ago
PetMeds® Adopts Limited Duration Shareholder Rights Plan
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Directors (the “Board”) has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the “Rights Plan”).
Charts implemented using Lightweight Charts™